Merck
MRK
#59
Rank
$252.00 B
Marketcap
$100.89
Share price
-1.35%
Change (1 day)
2.20%
Change (1 year)

Earnings for Merck (MRK)

Earnings in 2025 (TTM): $23.09 Billion USD

According to Merck's latest financial reports the company's current earnings are $64.23 Billion USD. In 2024 the company made an earning of $21.20 Billion USD, an increase over its 2023 earnings that were of $3.03 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Merck from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) $23.09 B8.88%
2024 $21.20 B598.75%
2023 $3.03 B-82.56%
2022 $17.40 B18.52%
2021 $14.68 B80.8%
2020 $8.12 B-34.26%
2019 $12.35 B30.45%
2018 $9.47 B30.2%
2017 $7.27 B35.93%
2016 $5.35 B-11.87%
2015 $6.07 B-66.29%
2014 $18.01 B183.88%
2013 $6.34 B-32.87%
2012 $9.45 B17.32%
2011 $8.05 B240.11%
2010 $2.36 B-84.96%
2009 $15.74 B66.09%
2008 $9.48 B68.8%
2007 $5.61 B52.38%
2006 $3.68 B-37.16%
2005 $5.86 B-11.41%
2004 $6.62 B-20.89%
2003 $8.37 B-11.74%
2002 $9.48 B-2.51%
2001 $9.72 B7.03%
2000 $9.08 B19.69%
1999 $7.59 B19.1%
1998 $6.37 B12.52%
1997 $5.66 B13.68%
1996 $4.98 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
$11.85 B-48.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$32.39 B 40.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$22.50 B-2.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$8.03 B-65.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$9.10 B-60.59%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
$9.32 B-59.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
$1.77 B-92.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
$16.41 B-28.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Abbott Laboratories
ABT
$8.13 B-64.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$8.24 B-64.30%๐Ÿ‡บ๐Ÿ‡ธ USA